Reuters logo
BRIEF-Ardelyx announces initiation of two clinical trials for RDX7675 for treatment of Hyperkalemia
January 3, 2017 / 11:46 AM / 9 months ago

BRIEF-Ardelyx announces initiation of two clinical trials for RDX7675 for treatment of Hyperkalemia

Jan 3 (Reuters) - Ardelyx Inc :

* Ardelyx announces initiation of two clinical trials for RDX7675 for treatment of Hyperkalemia

* Ardelyx Inc - to report data from onset-of-action study for RDX7675 in first half of year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below